SCHEMBL25580510

SCHEMBL25580510

c1ccc(-c2ccc(-c3ccc(N(c4ccc(-c5cccc(-c6ccccc6)c5-c5ccccc5-c5ccccc5)cc4)c4cccc5c4oc4ccccc45)cc3)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 3/20 0.41
▸ GGPS1 O95749 1/20 0.34
▸ CDC14B O60729 2/20 0.32
▸ CDC14A Q9UNH5 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ CSF1R P07333 1/20 0.32
▸ PDGFRB P09619 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ KIT P10721 1/20 0.32
▸ FLT3 P36888 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32
▸ PRKDC P78527 3/20 0.32
▸ PTGES2 Q9H7Z7 1/20 0.32
▸ PLA2G2A P14555 2/20 0.32
▸ PLA2G4A P47712 2/20 0.32
▸ NTRK1 P04629 1/20 0.31
▸ PLK3 Q9H4B4 1/20 0.31
▸ CA1 P00915 1/20 0.31
▸ CA2 P00918 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25580627 1.00 ALOX5 (0.41) ALOX5GGPS1CDC14BCDC14AMEN1
SCHEMBL25580703 0.97 ALOX5 (0.41) ALOX5GGPS1CDC14BCDC14AMEN1
SCHEMBL25580774 0.96 ALOX5 (0.46) ALOX5GGPS1CDC14BCDC14AMEN1
SCHEMBL25580677 0.95 ALOX5 (0.40) ALOX5GGPS1CDC14BCDC14AMEN1
SCHEMBL25580915 0.94 ALOX5 (0.43) ALOX5GGPS1PRKDCPTGES2PLA2G2A
SCHEMBL25580815 0.94 ALOX5 (0.43) ALOX5GGPS1PRKDCPTGES2PLA2G2A
SCHEMBL25580279 0.94 ALOX5 (0.39) ALOX5GGPS1CDC14BCDC14AMEN1
SCHEMBL25578851 0.94 ALOX5 (0.40) ALOX5GGPS1CDC14BCDC14AMEN1
SCHEMBL25580542 0.94 ALOX5 (0.40) ALOX5GGPS1CDC14BCDC14AMEN1
SCHEMBL25578841 0.94 ALOX5 (0.40) ALOX5GGPS1CDC14BCDC14AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ESR2 ALOX5 1615/4885GGPS1 4169/4885CDC14B 4631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback